Cargando…
A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM
Background: Although the diagnosis and treatment of glioblastoma (GBM) is significantly improved with recent progresses, there is still a large heterogeneity in therapeutic effects and overall survival. The aim of this study is to analyze gene expressions of transcription factors (TFs) in GBM so as...
Autores principales: | Cheng, Quan, Huang, Chunhai, Cao, Hui, Lin, Jinhu, Gong, Xuan, Li, Jian, Chen, Yuanbing, Tian, Zhi, Fang, Zhenyu, Huang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779830/ https://www.ncbi.nlm.nih.gov/pubmed/31632439 http://dx.doi.org/10.3389/fgene.2019.00906 |
Ejemplares similares
-
The overexpression of GPX8 is correlated with poor prognosis in GBM patients
por: Li, Sibo, et al.
Publicado: (2022) -
Predicting Metabolite–Disease Associations Based on LightGBM Model
por: Zhang, Cheng, et al.
Publicado: (2021) -
Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022) -
Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
por: Wen, Ya-Dan, et al.
Publicado: (2021) -
A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)